The human BTG2/TIS21/PC3 gene:: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene

被引:57
作者
Duriez, C
Falette, N
Audoynaud, C
Moyret-Lalle, C
Bensaad, K
Courtois, S
Wang, Q
Soussi, T
Puisieux, A
机构
[1] Ctr Leon Berard, Unite Oncol Mol, INSERM, U453, F-69373 Lyon 08, France
[2] Inst Curie Genotoxicol Tumeurs, F-75248 Paris, France
[3] Fac Pharm, F-69373 Lyon 08, France
关键词
BTG; promoter region; p53 binding site; breast cancer; mutation;
D O I
10.1016/S0378-1119(01)00825-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BTG2/TIS21/PC3 protein is involved in the regulation of G1/S transition of the cell cycle by inhibiting pRb function, suggesting that BTG2/TIS21/PC3 regulation is critical for normal cell growth and proliferation. To understand the regulatory mechanisms for the expression of BTG2/TIS21/PC3 we cloned the human gene. Potential binding sites for several transcription factors were identified in the 5'-flanking region of the gene. Transient expression assays with BTG2/TIS21/PC3 promoter deletions and electrophoretic mobility shift analysis identified a major wild-type p53 response element located -74 to -122 relative to the start codon. This genomic fragment was sufficient to constitute a promoter element in the presence of p53. The BTG2/TIS21/PC3 gene is an antiproliferative gene which maps within a chromosomal segment (1q32) frequently altered in breast adenocarcinomas. However, no mutations of BTG2/TIS21/PC3 were detected in breast cancer cells, suggesting that the inactivation of this gene is not a frequent genetic event during breast carcinogenesis. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:207 / 214
页数:8
相关论文
共 33 条
[21]  
Ji CH, 1996, J CELL BIOCHEM, V63, P478
[22]  
KASTAN MB, 1991, CANCER RES, V51, P6304
[23]  
LALLE P, 1995, ONCOGENE, V10, P2447
[24]   p53, the cellular gatekeeper for growth and division [J].
Levine, AJ .
CELL, 1997, 88 (03) :323-331
[25]  
Matsuda S, 1996, ONCOGENE, V12, P705
[26]   NEGATIVE GROWTH-REGULATION IN A GLIOBLASTOMA TUMOR-CELL LINE THAT CONDITIONALLY EXPRESSES HUMAN WILD-TYPE P53 [J].
MERCER, WE ;
SHIELDS, MT ;
AMIN, M ;
SAUVE, GJ ;
APPELLA, E ;
ROMANO, JW ;
ULLRICH, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6166-6170
[27]  
Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327
[28]  
PATHAK S, 1991, CANCER GENET CYTOGEN, V56, P309
[29]   A CHROMOSOME 12 CODING REGION IS JUXTAPOSED TO THE MYC PROTOONCOGENE LOCUS IN A T(8,12)(Q24,Q22) TRANSLOCATION IN A CASE OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
RIMOKH, R ;
ROUAULT, JP ;
WAHBI, K ;
GADOUX, M ;
LAFAGE, M ;
ARCHIMBAUD, E ;
CHARRIN, C ;
GENTILHOMME, O ;
GERMAIN, D ;
SAMARUT, J ;
MAGAUD, JP .
GENES CHROMOSOMES & CANCER, 1991, 3 (01) :24-36
[30]   BTG1, A MEMBER OF A NEW FAMILY OF ANTIPROLIFERATIVE GENES [J].
ROUAULT, JP ;
RIMOKH, R ;
TESSA, C ;
PARANHOS, G ;
FFRENCH, M ;
DURET, L ;
GAROCCIO, M ;
GERMAIN, D ;
SAMARUT, J ;
MAGAUD, JP .
EMBO JOURNAL, 1992, 11 (04) :1663-1670